Study title: Determination of dose-response curve for nebulised oxitropium-bromide in asthmatic preschool children using the Forced Oscillation Technique in a double blind randomized trial design.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: OXITROPIUM BROMIDE | |||||
ATC code: | |||||
Document link: oxitropium bromide_U98-0119_synopsis.pdf | |||||
Document date: 2011-09-23 | |||||
Study number: U98-0119 (Study No. 54535) | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |